Research Article
Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes
Table 1
Clinical characteristics of enrolled patients.
| | Variables | GYPXXY group (n = 9) | QXXY group (n = 9) | Nonfibrosis group (n = 12) |
| | Demographic characteristics | | Median age, years (range) | 37 (25–53) | 39 (26–65) | 39 (24–47) | | Males, n (%) | 5 (55.6) | 5 (55.6) | 7 (58.3) |
| | Laboratory data | | Median ALT, U/L (range) | 24 (10–53) | 23 (11–76) | 18 (8–88) | | Median HBV DNA (range), log10 IU/m | 5.1 (2.4, 8.1) | 4.8 (2.4, 8.5) | 2.8 (2.4, 8.4) |
| | Liver histology | | Inflammation activity, n (%) | | | | | 0, n (%) | 0 | 0 | 11 (91.7) | | 1, n (%) | 7 (77.8) | 6 (66.7) | 1 (8.3) | | 2, n (%) | 2 (22.2) | 3 (33.3) | 0 |
| | Fibrosis stage, n (%) | | F0, n (%) | 0 | 0 | 12 (100) | | F1, n (%) | 5 (55.6) | 4 (44.4) | 0 | | F2, n (%) | 4 (44.4) | 5 (55.6) | 0 |
|
|
Abbreviations: ALT, alanine aminotransferase. |
